Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
F3Q ~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6O0O   PDBj   RCSB PDB   PDBe
Header : APOPTOSIS
Title : crystal structure of BCL-2 G101V mutation with S55746
Release Data : 2019-05-22
Compound :
mol_id molecule chains synonym
1 Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2 A,C Bcl2-L-1,Apoptosis regulator Bcl-X
mutation: G101V,G101V,G101V
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli BL21  (taxid:511693)
gene: BCL2
expression_system_strain: BL21
Authors : Birkinshaw, R.W., Luo, C.S., Colman, P.M., Czabotar, P.E.
Keywords : BCL-2, S55746, complex, Protein-protein interface inhibitor, resistance mutation, APOPTOSIS
Exp. method : X-RAY DIFFRACTION ( 1.998 Å )
Citation :

Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.

Birkinshaw, R.W.,Gong, J.N.,Luo, C.S.  et al.
(2019)  Nat Commun  10 : 2385 - 2385

PubMed: 31160589
DOI: 10.1038/s41467-019-10363-1

Chain : A, C
UniProt : P10415 (BCL2_HUMAN)
Reaction : -
Chain : A, C
UniProt : Q07817 (B2CL1_HUMAN)
Reaction : -